TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.99 CNY | +3.46% |
|
+1.80% | +3.98% |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Attributable Profit Slips 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
1527c9c9bf.SV0kjzASmkyJzd6ua3sbu8sBY70aOcX-DVZuoMrFQVU.PB9W5lNL6yTT_bLxER4v_6RVN9tdSYC5VGQt1KGadS0xEWroX2CpHqSVvQ~abd2cecc41849ddef90b7d9a7309f3e5
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
34.99
CNY
Average target price
45.8
CNY
Spread / Average Target
+30.89%
High Price Target
45.8
CNY
Spread / Highest target
+30.89%
Low Price Target
45.8
CNY
Spread / Lowest Target
+30.89%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
